Tag Archives: World Health Organization

England set to be first country in the world to wipe out Hepatitis C virus

Hepatitis C set to be wiped out in England in THREE YEARS: Nation is in pole position to eliminate virus which can lead to cancer and liver disease

  • The NHS is set to eliminate the virus by 2025 – five years ahead of global targets
  • Deaths have fallen 35% in six years, well-exceeding the WHO’s target of 10%
  • England is set to be first country in the world to declare itself free from the virus 

Hepatitis C could be wiped out within two years thanks to a campaign to find and treat those most at risk.

The NHS is set to eliminate the virus by 2025 – five years ahead of global targets.

Deaths have fallen by 35 per cent in six years, well-exceeding the World Health Organisation’s target of 10 per cent.

It puts England in pole position to be the first country in the world to declare itself free from the virus, which can lead to liver disease and cancer.

Hepatitis C (pictured) could be wiped out within two years thanks to a campaign to find and treat those most at risk. The NHS is set to eliminate the virus by 2025 – five years ahead of global targets

WHAT IS HEPATITIS C? 

Hepatitis C is a virus that can infect the liver.

It is spread through contact with an infected person’s blood, such as sharing unsterilised needles, razors and toothbrushes.

The infection causes no symptoms until the liver has been significantly damaged, meaning many people have the infection without realising.

Symptoms can include muscle aches, a fever, feeling tired all the time, a loss of appetite, stomach ache and being sick. 

If left untreated, Hepatitis C can lead to serious and potentially life-threatening damage to the liver.

There are around 120,000 people in the UK and 2.4million people in the US who are living with chronic hepatitis.

Most aren’t aware that they are infected. 

<!- - ad: https://mads.dailymail.co.uk/v8/de/health/none/article/other/mpu_factbox.html?id=mpu_factbox_1 - ->

Advertisement

The progress comes after a five-year contract worth almost £1billion to buy antiviral drugs, which have a 95 per cent cure rate.

Dedicated ‘Find And Treat’ programmes have also helped the NHS drive down Hepatitis C cases among vulnerable communities such as the homeless.

Some 70,000 patients have been cured of the disease as part of the programme so far, which has also drastically reduced the need for liver transplants.

Rachel Halford, of the Hepatitis C Trust, described the progress made as ‘truly astounding’.

She said: ‘We now need a final concerted effort to make sure we reach all those that may be affected and reach elimination.’

Health chiefs said the number seeking liver transplants due to the virus fell from around 140 per year to less than 50 in 2020.

People in the most deprived communities have seen the biggest benefit, with 80 per cent of treatments provided to the most deprived half of the population.

This includes children born with the infection, with more than 100 children received infection-curing antivirals in the last year alone.

Professor Sir Stephen Powis, NHS England’s national medical director, said the NHS is ‘leading the world’ in the drive to save lives and eliminate Hepatitis C while also tackling a ‘significant’ health inequality.

He said: ‘Thanks to targeted screening and because the NHS has a proven track record of striking medicine agreements that give patients access to the latest drugs, we are on track to beat global targets and become the first country to eliminate Hepatitis C by 2030 – which will be a landmark achievement.’

Hepatitis C is a blood-borne virus which, left untreated, can cause liver cancer and liver failure.

It usually displays no symptoms until the virus causes enough damage to bring on liver disease.

Symptoms may include fatigue and difficulty concentrating and the virus is also linked to cardiovascular disease, mental health issues, kidney disease and musculoskeletal pain.

With the homeless at higher risk, the NHS has worked with charities including St Mungos to trace and treat those vulnerable to the disease.

Specialist teams have provided same-day screenings along with help to complete a full course of treatment.

Substance use, sharing toothbrushes, razors and other general lifestyle factors associated with sleeping rough are among a range of reasons putting the homeless at a higher risk of contracting Hepatitis C.

Sara Hide, of St Mungo’s in Oxford said: ‘With treatment for Hepatitis C now less invasive – a course of medication for 8-12 weeks – we’ve seen an uptake in people responding to our screening services. We also screen for other conditions at the same time to identify clients that might need extra health support.’

Health minister Lord Markham said: ‘I’m grateful to NHS staff and our partner charities like St Mungo’s for the fantastic progress that has been made so far. Deaths and prevalence of the virus have fallen consistently thanks to improvements in diagnosis and access to treatments.’

In other health news…

Table for one? Ladies who lunch eat more calories than those dining solo, study finds 

Stroke victims up to 48 PER CENT more likely to make full recovery when diagnosed using AI technology, trials suggest 

One in FOUR elderly Brits fear they will have to resort to DIY dentistry as top dentist hits out at ‘broken’ system 

Read original article here

England set to be first country in the world to wipe out Hepatitis C virus

Hepatitis C set to be wiped out in England in THREE YEARS: Nation is in pole position to eliminate virus which can lead to cancer and liver disease

  • The NHS is set to eliminate the virus by 2025 – five years ahead of global targets
  • Deaths have fallen 35% in six years, well-exceeding the WHO’s target of 10%
  • England is set to be first country in the world to declare itself free from the virus 

Hepatitis C could be wiped out within two years thanks to a campaign to find and treat those most at risk.

The NHS is set to eliminate the virus by 2025 – five years ahead of global targets.

Deaths have fallen by 35 per cent in six years, well-exceeding the World Health Organisation’s target of 10 per cent.

It puts England in pole position to be the first country in the world to declare itself free from the virus, which can lead to liver disease and cancer.

Hepatitis C (pictured) could be wiped out within two years thanks to a campaign to find and treat those most at risk. The NHS is set to eliminate the virus by 2025 – five years ahead of global targets

WHAT IS HEPATITIS C? 

Hepatitis C is a virus that can infect the liver.

It is spread through contact with an infected person’s blood, such as sharing unsterilised needles, razors and toothbrushes.

The infection causes no symptoms until the liver has been significantly damaged, meaning many people have the infection without realising.

Symptoms can include muscle aches, a fever, feeling tired all the time, a loss of appetite, stomach ache and being sick. 

If left untreated, Hepatitis C can lead to serious and potentially life-threatening damage to the liver.

There are around 120,000 people in the UK and 2.4million people in the US who are living with chronic hepatitis.

Most aren’t aware that they are infected. 

<!- - ad: https://mads.dailymail.co.uk/v8/de/health/none/article/other/mpu_factbox.html?id=mpu_factbox_1 - ->

Advertisement

The progress comes after a five-year contract worth almost £1billion to buy antiviral drugs, which have a 95 per cent cure rate.

Dedicated ‘Find And Treat’ programmes have also helped the NHS drive down Hepatitis C cases among vulnerable communities such as the homeless.

Some 70,000 patients have been cured of the disease as part of the programme so far, which has also drastically reduced the need for liver transplants.

Rachel Halford, of the Hepatitis C Trust, described the progress made as ‘truly astounding’.

She said: ‘We now need a final concerted effort to make sure we reach all those that may be affected and reach elimination.’

Health chiefs said the number seeking liver transplants due to the virus fell from around 140 per year to less than 50 in 2020.

People in the most deprived communities have seen the biggest benefit, with 80 per cent of treatments provided to the most deprived half of the population.

This includes children born with the infection, with more than 100 children received infection-curing antivirals in the last year alone.

Professor Sir Stephen Powis, NHS England’s national medical director, said the NHS is ‘leading the world’ in the drive to save lives and eliminate Hepatitis C while also tackling a ‘significant’ health inequality.

He said: ‘Thanks to targeted screening and because the NHS has a proven track record of striking medicine agreements that give patients access to the latest drugs, we are on track to beat global targets and become the first country to eliminate Hepatitis C by 2030 – which will be a landmark achievement.’

Hepatitis C is a blood-borne virus which, left untreated, can cause liver cancer and liver failure.

It usually displays no symptoms until the virus causes enough damage to bring on liver disease.

Symptoms may include fatigue and difficulty concentrating and the virus is also linked to cardiovascular disease, mental health issues, kidney disease and musculoskeletal pain.

With the homeless at higher risk, the NHS has worked with charities including St Mungos to trace and treat those vulnerable to the disease.

Specialist teams have provided same-day screenings along with help to complete a full course of treatment.

Substance use, sharing toothbrushes, razors and other general lifestyle factors associated with sleeping rough are among a range of reasons putting the homeless at a higher risk of contracting Hepatitis C.

Sara Hide, of St Mungo’s in Oxford said: ‘With treatment for Hepatitis C now less invasive – a course of medication for 8-12 weeks – we’ve seen an uptake in people responding to our screening services. We also screen for other conditions at the same time to identify clients that might need extra health support.’

Health minister Lord Markham said: ‘I’m grateful to NHS staff and our partner charities like St Mungo’s for the fantastic progress that has been made so far. Deaths and prevalence of the virus have fallen consistently thanks to improvements in diagnosis and access to treatments.’

In other health news…

Table for one? Ladies who lunch eat more calories than those dining solo, study finds 

Stroke victims up to 48 PER CENT more likely to make full recovery when diagnosed using AI technology, trials suggest 

One in FOUR elderly Brits fear they will have to resort to DIY dentistry as top dentist hits out at ‘broken’ system 

Read original article here

Biden administration will end monkeypox public health emergency

People line up to get a monkeypox vaccination at a new walk-up monkeypox vaccination site at Barnsdall Art Park on Tuesday, Aug. 9, 2022 in Hollywood, CA. 

Brian Van Der Brug | Los Angeles Times | Getty Images

The Biden administration will end the public health emergency declared in response to the monkeypox outbreak, as new infections have declined dramatically and vaccination rates have increased.

The Health and Human Services Department does not expect it will renew the emergency declaration after it expires on Jan. 31 “given the low number of cases today,” HHS Secretary Xavier Becerra said in a statement Friday.

“But we won’t take our foot off the gas — we will continue to monitor the case trends closely and encourage all at-risk individuals to get a free vaccine,” he said. “As we move into the next phase of this effort, the Biden-Harris Administration continues working closely with jurisdictions and partners to monitor trends, especially in communities that have been disproportionately affected.”

Becerra declared an emergency in August in an effort to accelerate a vaccination and education campaign as the virus was spreading swiftly in the gay community. The spread of the virus, dubbed “mpox” on Monday by the World Health Organization in order to reduce stigma associated with its name, has slowed drastically since.

Mpox has infected nearly 30,000 people and killed 15 in the U.S. since health officials confirmed the first domestic case in May, according to the Centers for Disease Control and Prevention. The U.S. outbreak is the largest in the world.

But infections have slowed dramatically since August, when new cases peaked at 638 per day on average. The U.S. is currently averaging about seven new cases a day, according to CDC data.

U.S. health officials have said the outbreak has slowed because vaccinations have increased dramatically, and people have changed their behavior in response to education campaigns about how to avoid infection.

CNBC Health & Science

Read CNBC’s latest global health coverage:

The vaccination campaign got off to a rocky start, with limited supplies resulting in long lines at clinics and protests in some cities. But vaccinations increased significantly after the White House created a task force and HHS declared a public health emergency.

More than 1.1 million doses of the Jynneos vaccine have been administered in the U.S. since the summer. CDC Director Dr. Rochelle Walensky has said about 1.7 million gay and bisexual people who are HIV positive or are taking medication to prevent HIV infection are at highest risk from mpox.

Mpox has spread primarily through sexual contact among men who have sex with men. The virus causes rashes resembling pimples or blisters that can develop in sensitive areas and be very painful. Though mpox is rarely fatal, people with compromised immune systems are at higher risk of severe disease.

The CDC, in a report published in late October, said it is unlikely the U.S. will eradicate mpox in the near future. The virus will probably continue to circulate at low level primarily in communities of men who have sex with men, according to CDC. Though anyone can catch mpox, there’s little evidence of the virus spreading widely in the general population so far, according to CDC.

The global mpox outbreak this year is the largest in history with more than 80,000 confirmed cases in more than 100 countries. The current outbreak is highly unusual because the virus is spreading widely between people in Europe and North America.

Historically, mpox spread at low levels in remote areas of West and Central Africa where people caught the virus from infected animals.

Read original article here

WHO renames monkeypox to avoid stigma

The World Health Organization on Monday renamed the viral disease monkeypox as “mpox” due to concerns about racism and stigmatization.

The new name will be used “simultaneously for one year” while the old one is phased out, the WHO said in a statement.

The transition period for adoption of the new name is aimed at mitigating concerns raised by experts “about confusion caused by a name change in the midst of a global outbreak,” it said.

Photo taken on Feb. 14, 2020, shows the headquarters of the World Health Organization in Geneva. (Kyodo) ==Kyodo

“When the outbreak of monkeypox expanded earlier this year, racist and stigmatizing language online, in other settings and in some communities was observed,” the Geneva-based organization said.

According to the WHO, the disease was named in 1970 when the first cases in humans were confirmed. The virus that causes the disease was first discovered in captive monkeys in Denmark in 1958.

The U.N. health body proposed mpox following guidelines it released in 2015 to “minimize unnecessary negative effects on nations, economies and people” when naming new human infectious diseases.

The guidelines recommend avoiding names that refer to animals, geographic locations and ethnic groups, such as “swine flu” and “Middle East Respiratory Syndrome.”

The names of diseases should consist of generic descriptive terms, based on the symptoms that they cause, the WHO said.

Monkeypox began spreading outside central and western Africa, where it is endemic, in May. As of Saturday, 81,107 cases and 55 deaths had been reported to the WHO this year in 110 countries and territories, mainly in men who have sex with men.

Although uncertainty remains, rodents appear to be the natural reservoir of the virus, it said.

 

(function(d, s, id){ var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) {return;} js = d.createElement(s); js.id = id; js.src = "https://connect.facebook.net/en_US/sdk.js"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));

Read original article here

WHO renames monkeypox as ‘mpox’



CNN
 — 

The World Health Organization announced Monday that “mpox” is now the preferred name for monkeypox.

“Both names will be used simultaneously for one year while ‘monkeypox’ is phased out,” the organization said.

Monkeypox was named in 1970, more than a decade after the virus that causes the disease was discovered in captive monkeys, the organization said. But monkeypox probably didn’t start in monkeys – its origin is still unknown – and the virus can be found in several other kinds of animals. The name was created before WHO published best practices for naming diseases in 2015.

Scientists and experts have pushed since the start of the recent outbreak to change the name to avoid discrimination and stigma that could steer people away from testing and vaccination. Stigma has been an ongoing concern as the outbreak has largely affected men who have sex with men. In the United States, Black and Hispanic people have been disproportionately affected, data from the US Centers for Disease Control and Prevention show.

This summer, New York City Health Commissioner Dr. Ashwin Vasan sent a letter to WHO to urge it to act quickly on a new name, saying there’s “growing concern for the potentially devastating and stigmatizing effects that the messaging around the ‘monkeypox’ virus can have on these already vulnerable communities.”

In August, WHO encouraged people to propose new names for monkeypox by submitting suggestions to it website. WHO said Monday that the consultation process included experts from medical, scientific, classification and statistics advisory committees “which constituted of representatives from government authorities of 45 different countries.”

“The issue of the use of the new name in different languages was extensively discussed. The preferred term mpox can be used in other languages,” WHO said in its statement.

WHO said Monday that “monkeypox” will remain searchable in the International Classification of Diseases in order to allow access to historic information, and the one-year period when both will be used allows time for publications and communications to be updated.

So far, more than 81,000 monkeypox cases in 110 cases have been reported to WHO in the recent outbreak. WHO says the global risk remains moderate, and outside of countries in West and Central Africa, the outbreak continues to primarily affect men who have sex with men.

Read original article here

WHO and CDC declare measles a global imminent threat

A combined report from two major public health bodies has declared measles an “eminent threat” to the global community.

Released on Thursday, the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) feared that a record decline of measles vaccination rates and persistent large outbreaks meant that the respiratory virus was an “imminent threat in every region of the world”.

WHO Director-General Dr Tedros Adhanom Ghebreyesus said it was “absolutely critical” that immunization programs were bought back on track to avoid what he said is a “preventable disease”.

WHO Director-General Dr Tedros Adhanom Ghebreyesus says vaccinations are the most important factor in minimizing the threat of measles.
Pacific Press/LightRocket via Ge

“The paradox of the pandemic is that while vaccines against Covid-19 were developed in record time and deployed in the largest vaccination campaign in history, routine immunization programs were badly disrupted, and millions of kids missed out on lifesaving vaccinations against deadly diseases like measles,” said Dr Ghebreyesus.

According to the WHO, India, Somalia and Yemen are the three countries with the largest measles outbreak.

While measles is thought to be one of the most contagious viruses, the measles, mumps and rubella-containing vaccine administered during childhood is considered the best defence to reduce future outbreaks.

In Australia, the shot is free for children between 12 to 18 months. People under the age of 20, refugees and humanitarian entrants may also be eligible for a catch up vaccine.

The CDC states that nine out of 10 people who are not vaccinated against the disease will become infected in the advent of exposure.

A child is given a vaccine following a measles outbreak in India, on Nov. 23, 2022.
AFP via Getty Images

The virus is transmitted through water droplets released in the sneezes and coughs of infected people. Common symptoms include fever, cold-symptoms, conjunctivitis and red and blotchy rashes that first appear around the face and hairline before spreading elsewhere around the body.

The characteristic rash generally emerges three to four days after the initial symptoms develop.

Last week, visitors who travelled through Melbourne airport were asked to monitor for symptoms until Saturday, December 3.

Three confirmed cases were recorded in a family travelling to Melbourne from Singapore, bringing the total number of confirmed cases in 2022 to five.

The passengers boarded a Qantas flight QF36/ Emirates flight EK5036 in Singapore on Monday and landed at Melbourne Tullamarine Airport on Tuesday at about 6:10 am. They were reportedly inside the airport until 8:40 am.

Victoria’s deputy chief health officer Deborah Friedman urged people who developed symptoms to seek medical care, and to wear a mask and call ahead to ensure they can be isolated from others.

A vial of the measles/rubella vaccine.
AFP via Getty Images

She said young children and adults with weakened immune systems are the most at risk of serious illness.

“Measles is a highly infectious viral disease that spreads quickly with close contact, especially in those who are not fully vaccinated,” said Ms Friedman.

This comes as NSW reported its first case of measles in two years in September this year. A person in their 50s was infected after traveling to Asia and developed symptoms after returning to Sydney.

Read original article here

WHO: Tuberculosis cases rise for the first time in years

GENEVA (AP) — The number of people infected with tuberculosis, including the kind resistant to drugs, rose globally for the first time in years, according to a report Thursday by the World Health Organization.

The U.N. health agency said more than 10 million people worldwide were sickened by tuberculosis in 2021, a 4.5% rise from the year before. About 1.6 million people died, it said. WHO said about 450,000 cases involved people infected with drug-resistant TB, 3% more than in 2020.

Dr. Mel Spigelman, president of the non-profit TB Alliance, said more than a decade of progress was lost when COVID-19 emerged in 2020.

“Despite gains in areas like preventative therapy, we are still behind in just about every pledge and goal regarding TB,” Spigelman said.

WHO also blamed COVID-19 for much of the rise in TB, saying the pandemic “continues to have a damaging impact on access to TB diagnosis and treatment.” It said progress made before 2019 has since “slowed, stalled or reversed.”

With fewer people being diagnosed with the highly infectious disease, more patients unknowingly spread tuberculosis to others in outbreaks that may not have been spotted in countries with weak health systems.

WHO reported that the number of people newly identified with TB fell from 7 million in 2019 to 5.8 million in 2020.

WHO also said COVID-19 restrictions, including lockdowns and physical distancing protocols, also hampered TB treatment services and may have prompted some people to skip going to health facilities for fear of catching coronavirus. Officials added that the downturn in the global economy was also a factor, saying that about half of all TB patients and their families face “catastrophic total costs” due to their treatment. WHO called for more countries to cover all TB diagnosis and treatment expenses.

After COVID-19, TB is the world’s deadliest infectious disease. It is caused by bacteria that typically affects the lungs. The germs are mostly spread from person to person in the air, such as when an infected individual coughs or sneezes.

TB mostly affects adults, particularly those who are malnourished or have other conditions like HIV; more than 95% of cases are in developing countries.

According to the WHO report, only one in three people with drug-resistant TB are receiving treatment.

“Drug-resistant TB is curable, but alarmingly, cases are on the rise for the first time in years,” said Dr. Hannah Spencer, who is with Doctors Without Borders in South Africa. “It’s urgent that shorter, safer and more effective treatments are scaled up now.”

Spencer called for lowering the prices of TB treatment so a complete treatment course costs no more than $500.

WHO also said ongoing conflicts in eastern Europe, Africa and the Middle East have worsened the options for patients seeking TB diagnosis and treatment.

Ukraine had one of the world’s worst TB epidemics even before Russia invaded the country in February. Health experts fear the inability of patients to get treated could fuel the rise of more drug-resistant TB across the region.

While TB patients displaced by the war can seek care in Ukraine, the country has seen a shortage of key medicines and authorities face challenges in keeping track of patients.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Read original article here

WHO Warns of Surge in Chronic Disease by 2030 If People Don’t Start Exercising

Image: Timothy A. Clary (Getty Images)

A new report from the World Health Organization finds that our collective lack of exercise will exact a heavy toll in the years to come if nothing changes. The report estimates that there will be nearly a half-billion new cases of noncommunicable disorders like heart disease and diabetes due to physical inactivity by 2030. It also found that many countries are doing little to help people stay active, such as building safer walkable roads.

The findings come from the WHO’s first ever global status report on physical activity. It analyzes data from 194 countries on how often people are physically active and the policies put in place by countries to promote physical activity. As part of the report, the authors also calculated the potential effects on healthcare systems if people’s level of exercise stayed the same up through 2030. These latter estimates will be published in an upcoming paper but can be viewed in a preprint from the Lancet that was released last week.

Often, more than one factor contributes to a person’s heart disease or other noncommunicable disorder (NCD), and only some of these risk factors are preventable or can change for the better. But many studies have shown that any amount of exercise, no matter a person’s age, can help people stay healthier. Based on other research, the authors tried to calculate the fraction of preventable NCDs strongly tied to a lack of physical activity that would emerge over the next decade, focusing specifically on seven major conditions: heart disease, stroke, type 2 diabetes, hypertension, certain cancers, dementia, and depression.

Overall, the authors estimated that almost 500 million new cases of these conditions would occur between 2020 and 2030 worldwide. These cases would also rack up around $300 billion (USD) in direct medical costs during that time period and about $27 billion annually by 2030. Most of these cases (about 74%) would occur in low-to-middle income countries, but the economic costs would be greater in higher-income countries (about 64%).

“This study calls for urgent actions by countries to prioritize investments in interventions that reduce this modifiable risk factor,” the authors wrote.

So far, though, it appears that most countries are falling far short of these investments. The WHO report found less than half of countries even have a national physical activity policy. Only 30% of countries have stated national physical activity guidelines for all age groups. And while most countries do have some way of tracking how active adults are, less than 30% do the same for children younger than 5. The implementation of many of these policies, such as nationally organized running or walking events, have been further disturbed by the covid-19 pandemic, the report authors note.

There are a multitude of reasons why people aren’t as physically active as they could be, and many of those are out of people’s control, such as the kind of job and working hours they have. But the report also highlights the actions that governments are failing to take to encourage a more active lifestyle for residents. Only 40% of countries, for instance, have standards for designing roads that would make walking and biking safer.

“We need more countries to scale up implementation of policies to support people to be more active through walking, cycling, sport, and other physical activity. The benefits are huge, not only for the physical and mental health of individuals, but also for societies, environments, and economies,” said Tedros Adhanom Ghebreyesus, WHO Director-General, in a statement announcing the report. “We hope countries and partners will use this report to build more active, healthier, and fairer societies for all.”

Some of the recommendations provided by the WHO to encourage physical activity include more public open spaces, walkable roads and other infrastructure, and more sports or gym activities in school. There’s also a need for better data collection, since there’s little known about people’s access to parks and other ways to help people become more active.

Read original article here

Maiden Pharma: Gambia child deaths linked to cough syrups made in India, says WHO

The deaths of dozens of young children in Gambia from acute kidney injuries may be linked to contaminated cough and cold syrups made by an Indian drug manufacturer, the World Health Organization said on Wednesday.

The findings, announced by WHO Director-General Tedros Adhanom Ghebreyesus, followed tests on several medicinal syrups that were suspected of causing 66 child deaths in the tiny West African country.

Tedros told reporters that the UN agency was conducting an investigation with Indian regulators and the company that made the syrups, New Delhi-based Maiden Pharmaceuticals Ltd.

Maiden Pharma declined to comment, while calls and messages to the Drugs Controller General of India went unanswered.

The WHO issued a medical product alert on Wednesday asking regulators to remove Maiden Pharma goods from the market.

The products may have been distributed elsewhere through informal markets, but had so far been identified only in Gambia, the WHO said in its alert.

The alert covers four products: Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

Lab analysis confirmed “unacceptable” amounts of diethylene glycol and ethylene glycol, which can be toxic and lead to acute kidney injury, the WHO said.

Medical officers in Gambia raised the alarm in July, after dozens of children began falling ill with kidney problems. The deaths confounded medics before a pattern emerged: dozens of patients younger than five were falling ill three to five days after taking a locally sold paracetamol syrup.

Gambia’s director of health services, Mustapha Bittaye, said similar problems have been detected in other syrups but that the ministry is awaiting confirmation of the results.

He said the number of deaths has tapered off in recent weeks and that the sale of products made by Maiden Pharmaceuticals was banned. However, until recently, some of the syrups were still being sold in private clinics and in hospitals, he said.

Gambia’s Medicines Control Agency sent a letter on Tuesday to health professionals ordering them to stop selling any of the products listed by WHO.

Maiden Pharmaceuticals manufactures medicines at its facilities in India, which it then sells domestically as well as exporting them to countries in Asia, Africa and Latin America, according to its website.

Read original article here

Worries over stigma are driving a push to rename monkeypox, but the process is slow



CNN
 — 

Since the beginning of the monkeypox outbreak, scientists and activists have pushed for the name of the virus and the disease to be changed to something “non-discriminatory” and “non-stigmatizing.”

Public health experts have worried that stigma could steer people away from getting tested and vaccinated. A new name can help slow the spread of the disease, they say, but it needs to come quickly.

Globally, nearly 60,000 cases have been identified, placing the name “monkeypox” in individuals’ medical files. The World Health Organization’s director-general promised in June that a change in the name was coming “as soon as possible,” and WHO said it was working with experts to change the name of the virus, its variants and the disease it causes.

But that was months ago.

Typically, the scientist who isolates a virus gets to suggest a name. The naming of the species is the responsibility of WHO’s International Committee on Taxonomy of Viruses.

Scientists have been calling this virus “monkeypox” for 64 years.

In 1958, researcher Preben von Magnus and his team in Copenhagen, Denmark, discovered two outbreaks of a “pox-like disease” in a colony of crab-eating macaque monkeys that their lab used for polio vaccine production and research.

The first human case of monkeypox wasn’t documented until 1970. Scientists discovered a case in a 9-month-old boy in the Democratic Republic of Congo. The child recovered from the monkeypox infection but died six days later from measles. After that, cases of the painful disease were documented in West and Central Africa.

Cases in other places were almost all linked to travel, according to the CDC. But in 2018, the agency noted that over the previous decade, more human cases had been reported in countries that had not seen the disease in several decades. This emergence, it said, was a “global health security concern.”

The global push for the name change started this year, when an outbreak took off in countries where monkeypox was not commonly found.

The naming process had already been underway to reconsider the names of all orthopoxvirus species, WHO said in an email to CNN, including cowpox, horsepox, camelpox, raccoonpox and skunkpox, as well as monkeypox.

According to WHO taxonomy committee member Colin McInnes, the panel has a mandate to bring “virus species nomenclature into line with the way that most other forms of life are named.”

Traditionally, poxviruses were named after the animal in which the disease was first spotted, but that created some inconsistencies, he said.

Monkeypox probably didn’t start in monkeys. Its origin is still unknown. The virus can be found in several other kinds of animals like Gambian giant rats, dormice and a couple of species of squirrels.

McInnes, who is deputy director and principal scientist with the Moredun Group, which develops vaccines and tests for livestock and other animals, studies squirrelpox – which also may be in line for a name change. He has been looking into the feasibility of producing a vaccine against the virus, which can be fatal for red squirrels in the UK.

The current species known as “monkeypox virus” and the others would then be renamed to “orthopoxvirus ‘something,’ ” he said in an email to CNN.

“It is the ‘something’ that is currently being debated,” McInnes wrote.

He said some scientists would prefer that the monkeypox name be kept in order to retain the link to 50 years of published research. Others would like a totally different name.

The WHO committee has until June 2023 to suggest changes.

In August, WHO announced that a group of experts had come up with new names for the clades, or variants, of monkeypox. Prior to more modern conventions about names, scientists would name a variant for the region where it emerged and was circulating.

Now, to remove any stigma that comes with naming a disease for a region or country, the Congo Basin clade will be called clade I. The former West African clade is clade II. A subvariant, clade IIb, is what is primarily in circulation in the current outbreak.

Many scientists say WHO needs to work with more urgency.

In July, after weeks had gone by no action, the New York City health commissioner sent a letter to WHO, urging it to “act in this moment before it is too late.” It cited “growing concern for the potentially devastating and stigmatizing effects that the messaging around the ‘monkeypox’ virus can have on these already vulnerable communities.”

Since the outbreak has largely affected gay and bisexual men and other men who have sex with men, stigma has been an ongoing concern for WHO Director-General Tedros Adhanom Ghebreyesus.

“Stigma and discrimination can be as dangerous as any virus,” Tedros said when he declared monkeypox a global health emergency in July.

In the US, the virus is disproportionately affecting Black and Hispanic people, according to the CDC. Local public health data also shows that fewer members of either community are getting the monkeypox vaccine.

Experts are concerned that in addition to the barriers that make access to any kind of health care difficult, some people may not get the vaccine or get tested because of the stigma associated with the disease.

In the WHO 2015 naming conventions, the organization encouraged those who name diseases to avoid places, names, occupations and animals due to stigmatization.

In August, WHO encouraged people who want to propose new names for monkeypox to submit suggestions to its website. More than 180 ideas have been suggested, some with a wide mix of creative explanations.

Some – like lopox, ovidpox, mixypox and roxypox – had no explanation.

A handful – like rodentpox, bonopox and alaskapox – may have been facetious.

Johanna Vogl, who submitted “greypox,” wrote that the name “refers to a phenotypic mark of the disease, greyish blisters and is not associated with human skin color nor a location, group or animal.”

Other suggestions come with more robust scientific explanations. Dr. Jeremy Faust, an emergency medicine physician at Brigham and Women’s Hospital in Boston and an instructor in emergency medicine at Harvard, suggested changing the name to opoxid-22.

“While the monkeypox virus causing the current outbreak is not a novel pathogen, I propose that due to its designation as a public health emergency of international concern, renaming it is warranted,” Faust wrote in his proposal. He added that although this particular lineage of the virus seems to have originated before 2022, using this year may “limit confusion.”

Opoxid-22 reflects what’s known about the virus while removing “monkey” from the name.

Faust said he was bothered by the inaccuracy of the monkeypox name and the stigma it conveyed. But he said he submitted the name when he was waiting for some other work to finish.

“Honestly, I was just procrastinating,” Faust said.

He said that if WHO picked his name, it could help more people seek treatment, testing and care.

“This is important,” Faust said. “The right name should sound dry, technical, boring, so people aren’t afraid to say that they have that problem, right?”

Rossi Hassad, a professor of research and statistics at Mercy College and a fellow of the American College of Epidemiology, submitted a few names including zpox-22, zopox-22, zovid-22, hpox22 and hpi-22.

His proposal argues that given the uncertainty over where the virus originated, a more general name derived from a zoonosis – meaning a disease that can be transmitted from animals to humans – would eliminate the word “monkey” and be more inclusive.

Adding “22” would reflect the year in which scientists learned about this “outbreak with unusual and worrisome human-to-human transmission,” the proposal says.

Hassad said he was motivated to submit names because the word “monkey” can carry a lot of negative connotations.

“It has been used in racial and racist slurs against certain groups. I think it will be disingenuous not to recognize the damage that that word has done,” he said. “It is also scientifically incorrect. It’s a misnomer. If we want to be scientific, we have to be correct.”

Some US health departments aren’t waiting for WHO, but the change is inconsistent.

San Francisco’s Department of Health calls it MPX. Chicago’s calls it MPV. Other cities hit hard by the outbreak, including Houston, New York City and Philadelphia, have stuck with the traditional name, as has the CDC.

Daniel Driffin, an HIV patient advocate and a consultant with NMAC, a national organization that works for health equity and racial justice to end the HIV epidemic, said he hopes the name will change. At the same time, he is disappointed that it wasn’t until this outbreak, when people outside of Africa were widely affected, that the pushing for the change started.

“It’s a name steeped in racism. It’s a day late and a dollar short. But I support the change and think it will help,” Driffin said. “Think about the populations who will continue to be impacted disproportionately with this disease. It’s been Black and brown folks, so if we can strip racist oppressive tendencies from the nomenclature, I think we have to do that.”



Read original article here